Ipamorelin is a selective growth hormone secretagogue that stimulates GH release without affecting cortisol, prolactin, or ACTH. Review of preclinical research on mechanisms, selectivity, and applications.
Peptide Profiles
Peptide Profiles collects compound-by-compound research overviews covering mechanisms, published studies, and practical context. Use this archive to compare individual peptides and explore the literature behind them.
TB-500: Everything Researchers Need to Know
TB-500 is a synthetic analog of thymosin beta-4. This research review covers its molecular mechanisms, preclinical evidence in wound healing, cardiac research, and connective tissue models.
Selank + Semax: Why Researchers Stack These Two
Why researchers study Selank and Semax together — complementary GABAergic anxiolytic and neurotrophin-mediated cognitive mechanisms, functional connectivity research, and the science behind combination nootropic peptide protocols.
Semax: The Brain Peptide Designed for Stroke Recovery
A comprehensive review of Semax (Met-Glu-His-Phe-Pro-Gly-Pro), the ACTH(4-7) analog. Covers BDNF/NGF upregulation, dopaminergic and serotonergic modulation, cerebrovascular protection, and neuroprotective mechanisms in published preclinical research.
Selank: The Russian Anti-Anxiety Peptide That Doubles as a Nootropic
A research review of Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro), the synthetic tuftsin analog developed at the Russian Academy of Sciences. Covers GABAergic modulation, BDNF expression, enkephalin stabilization, and cognitive enhancement findings in preclinical models.
GHK-Cu: 30 Years of Copper Peptide Research
A comprehensive review of 50+ years of published research on GHK-Cu (glycyl-L-histidyl-L-lysine copper), covering gene expression modulation, extracellular matrix remodeling, antioxidant mechanisms, and tissue repair studies.
GLP-3R: The First Triple Receptor Agonist (And Why It Matters)
A comprehensive review of published Phase 2 and Phase 3 clinical trial data on retatrutide (LY3437943), the first triple GLP-1/GIP/glucagon receptor agonist peptide, including the TRIUMPH program and hepatic research findings.